Literature DB >> 16492956

Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.

P Bot, B A Semmekrot, J van der Stappen.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16492956      PMCID： PMC2672676          DOI： 10.1136/adc.2004.066431

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  6 in total

1.  Neonatal paroxetine withdrawal syndrome.

Authors:  J A Stiskal; N Kulin; G Koren; T Ho; S Ito
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  Withdrawal reactions of a premature neonate after maternal use of paroxetine.

Authors:  I J Nijhuis; G W Kok-Van Rooij; A N Bosschaart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

3.  Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

Authors:  G K Isbister; A Dawson; I M Whyte; F H Prior; C Clancy; A J Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

4.  Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.

Authors:  Emilio J Sanz; Carlos De-las-Cuevas; Anne Kiuru; Andrew Bate; Ralph Edwards
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

5.  Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.

Authors:  H Nordeng; R Lindemann; K V Perminov; A Reikvam
Journal:  Acta Paediatr       Date:  2001-03       Impact factor: 2.299

6.  Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.

Authors:  Philip Sanford Zeskind; Laura E Stephens
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124
  6 in total
  6 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  Neurotoxicol Teratol       Date:  2006-12-08       Impact factor: 3.763

3.  Prenatal Venlafaxine Exposure-Induced Neurocytoarchitectural and Neuroapoptotic Degeneration in Striatum and Hippocampus of Developing Fetal Brain, Manifesting Long-term Neurocognitive Impairments in Rat Offspring.

Authors:  K P Singh; Prashant Sharma; Manish Singh
Journal:  Neurotox Res       Date:  2022-07-12       Impact factor: 3.978

4.  Use of antidepressants during pregnancy in the Netherlands: observational study into postpartum interventions.

Authors:  Noera Kieviet; Fokke de Jong; Fedde Scheele; Koert M Dolman; Adriaan Honig
Journal:  BMC Pregnancy Childbirth       Date:  2017-01-11       Impact factor: 3.007

Review 5.  The use of psychotropic medication during pregnancy: how about the newborn?

Authors:  Noera Kieviet; Koert M Dolman; Adriaan Honig
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-28       Impact factor: 2.570

6.  Cardiac dysfunction and prenatal exposure to venlafaxine.

Authors:  Ana R Araújo; Mónica Marçal; Madalena Tuna; Rui Anjos
Journal:  Clin Case Rep       Date:  2016-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.